Final Approval Of $40M Settlement Granted In Securities Fraud Class Action

( March 5, 2025, 11:17 AM EST) -- BALTIMORE — A federal judge in Maryland granted final approval of a $40 million settlement in a securities fraud class action brought by investors against a COVID-19 vaccine contractor that experienced contamination issues at its Bayview, Md., manufacturing facility and several of its executives....

Attached Documents

Related Sections